{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:03:41Z","timestamp":1778519021311,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"DOI":"10.7759\/cureus.84886","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:49:07Z","timestamp":1748346547000},"source":"Crossref","is-referenced-by-count":2,"title":["Stereotactic Radiotherapy for Locally Recurrent and Metastatic Soft Tissue Sarcoma"],"prefix":"10.7759","author":[{"given":"Anastasia","family":"Stergioula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Kokkali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Kormas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Memos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaggelos","family":"Pantelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Soft Tissue and Bone Tumours: WHO Classification of Tumours, 5th Edition, Volume 3","year":"2020","unstructured":"Soft Tissue and Bone Tumours. WHO Classification of Tumours, 5th Edition, Volume 3. World Health Organization, Geneva, Switzerland; 2020."},{"key":"ref2","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma (Version 2). (2023). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/sarcoma.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02674-y","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"132","author":"Hayes AJ","year":"2025","unstructured":"Hayes AJ, Nixon IF, Strauss DC, et al.. UK guidelines for the management of soft tissue sarcomas. Br J Cancer. 2025, 132:11-31. 10.1038\/s41416-024-02674-y","journal-title":"Br J Cancer"},{"key":"ref4","unstructured":"Survival rates for soft tissue sarcoma. https.\/\/www.cancer.org\/cancer\/types\/soft-tissue-sarcoma\/detection-diagnosis-staging\/survival-rates.html."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25538","article-title":"Trends in survival for patients with metastatic soft-tissue sarcoma","volume":"117","author":"Italiano A","year":"2011","unstructured":"Italiano A, Mathoulin-Pelissier S, Cesne AL, et al.. Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer. 2011, 117:1049-54. 10.1002\/cncr.25538","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5467057","article-title":"Treatment patterns and survival among adult patients with advanced soft tissue sarcoma: a retrospective medical record review in the United Kingdom, Spain, Germany, and France","volume":"2018","author":"Nagar SP","year":"2018","unstructured":"Nagar SP, Mytelka DS, Candrilli SD, et al.. Treatment patterns and survival among adult patients with advanced soft tissue sarcoma: a retrospective medical record review in the United Kingdom, Spain, Germany, and France. Sarcoma. 2018, 2018:5467057. 10.1155\/2018\/5467057","journal-title":"Sarcoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.150","article-title":"Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens\u2014a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study","volume":"17","author":"Van Glabbeke M","year":"1999","unstructured":"Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al.. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens\u2014a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 1999, 17:150-7. 10.1200\/JCO.1999.17.1.150","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.26","article-title":"Systemic treatment of soft-tissue sarcoma\u2014gold standard and novel therapies","volume":"11","author":"Linch M","year":"2014","unstructured":"Linch M, Miah AB, Thway K, Judson IR, Benson C. Systemic treatment of soft-tissue sarcoma\u2014gold standard and novel therapies. Nat Rev Clin Oncol. 2014, 11:187-202. 10.1038\/nrclinonc.2014.26","journal-title":"Nat Rev Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100913","article-title":"Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions","volume":"7","author":"Boyce-Fappiano D","year":"2022","unstructured":"Boyce-Fappiano D, Damron EP, Farooqi A, et al.. Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions. Adv Radiat Oncol. 2022, 7:100913. 10.1016\/j.adro.2022.100913","journal-title":"Adv Radiat Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.05.017","article-title":"Local control outcomes using stereotactic body radiation therapy or surgical resection for metastatic sarcoma","volume":"114","author":"Gutkin PM","year":"2022","unstructured":"Gutkin PM, von Eyben R, Chin A, et al.. Local control outcomes using stereotactic body radiation therapy or surgical resection for metastatic sarcoma. Int J Radiat Oncol Biol Phys. 2022, 114:771-9. 10.1016\/j.ijrobp.2022.05.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2020.01.005","article-title":"Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma","volume":"32","author":"Tetta C","year":"2020","unstructured":"Tetta C, Londero F, Micali LR, et al.. Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma. Clin Oncol (R Coll Radiol). 2020, 32:303-15. 10.1016\/j.clon.2020.01.005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2014.09.010","article-title":"Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group","volume":"27","author":"Falk AT","year":"2015","unstructured":"Falk AT, Moureau-Zabotto L, Ouali M, et al.. Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group. Clin Oncol (R Coll Radiol). 2015, 27:48-55. 10.1016\/j.clon.2014.09.010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2023.06.029","article-title":"Management of oligometastatic\/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches","volume":"28","author":"Llacer-Moscardo C","year":"2024","unstructured":"Llacer-Moscardo C, Moureau-Zabotto L, Ollivier L, et al.. Management of oligometastatic\/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches. Cancer Radiother. 2024, 28:93-102. 10.1016\/j.canrad.2023.06.029","journal-title":"Cancer Radiother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-814245-5.00002-5","article-title":"A technical overview of the CyberKnife system","author":"Kilby W","year":"2020","unstructured":"Kilby W, Naylor M, Dooley J R, Maurer C R Jr, Sayeh S. A technical overview of the CyberKnife system. Handbook of Robotic and Image-Guided Surgery. Abedin-Nasab MH (ed): Elsevier, Amsterdam, Netherlands; 2020. 2:15-38. 10.1016\/B978-0-12-814245-5.00002-5"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1118\/1.3462971","article-title":"QA for helical tomotherapy: report of the AAPM Task Group 148","volume":"37","author":"Langen KM","year":"2010","unstructured":"Langen KM, Papanikolaou N, Balog J, et al.. QA for helical tomotherapy: report of the AAPM Task Group 148. Med Phys. 2010, 37:4817-53. 10.1118\/1.3462971","journal-title":"Med Phys"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox BW","year":"2012","unstructured":"Cox BW, Spratt DE, Lovelock M, et al.. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012, 83:e597-605. 10.1016\/j.ijrobp.2012.03.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110078","article-title":"Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): a multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology)","volume":"191","author":"Franceschini D","year":"2024","unstructured":"Franceschini D, Greto D, Dicuonzo S, et al.. Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): a multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology). Radiother Oncol. 2024, 191:110078. 10.1016\/j.radonc.2023.110078","journal-title":"Radiother Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-018-0912-5","article-title":"Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma","volume":"123","author":"Loi M","year":"2018","unstructured":"Loi M, Duijm M, Baker S, Rossi L, Grunhagen D, Verhoef C, Nuyttens J. Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma. Radiol Med. 2018, 123:871-8. 10.1007\/s11547-018-0912-5","journal-title":"Radiol Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.08.028","article-title":"Stereotactic body radiation therapy for lung metastases from sarcoma in oligometastatic patients: a phase 2 study","volume":"114","author":"Navarria P","year":"2022","unstructured":"Navarria P, Baldaccini D, Clerici E, et al.. Stereotactic body radiation therapy for lung metastases from sarcoma in oligometastatic patients: a phase 2 study. Int J Radiat Oncol Biol Phys. 2022, 114:762-70. 10.1016\/j.ijrobp.2022.08.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.10.017","article-title":"SABR for sarcoma lung metastases: indications for treatment and guidance for patient selection","volume":"118","author":"Farooqi AS","year":"2024","unstructured":"Farooqi AS, Yoder AK, Lin HY, et al.. SABR for sarcoma lung metastases: indications for treatment and guidance for patient selection. Int J Radiat Oncol Biol Phys. 2024, 118:971-8. 10.1016\/j.ijrobp.2023.10.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26078","article-title":"Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: high rates of local control with favorable toxicity","volume":"122","author":"Baumann BC","year":"2020","unstructured":"Baumann BC, Bernstein KA, DeLaney TF, et al.. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: high rates of local control with favorable toxicity. J Surg Oncol. 2020, 122:877-83. 10.1002\/jso.26078","journal-title":"J Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.11.052","article-title":"Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival","volume":"82","author":"Dhakal S","year":"2012","unstructured":"Dhakal S, Corbin KS, Milano MT, Philip A, Sahasrabudhe D, Jones C, Constine LS. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys. 2012, 82:940-5. 10.1016\/j.ijrobp.2010.11.052","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9132359","article-title":"Treatment of sarcoma lung metastases with stereotactic body radiotherapy","volume":"2018","author":"Lindsay AD","year":"2018","unstructured":"Lindsay AD, Haupt EE, Chan CM, Spiguel AR, Scarborough MT, Zlotecki RA, Gibbs PC. Treatment of sarcoma lung metastases with stereotactic body radiotherapy. Sarcoma. 2018, 2018:9132359. 10.1155\/2018\/9132359","journal-title":"Sarcoma"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245978","article-title":"Brain metastases from adult sarcomas: a retrospective cohort study from the hellenic group of sarcomas and rare cancers (HGSRC)","volume":"10","author":"Kokkali S","year":"2021","unstructured":"Kokkali S, Vini L, Stergioula A, Kyriazoglou A, Vassos N, Boukovinas I. Brain metastases from adult sarcomas: a retrospective cohort study from the hellenic group of sarcomas and rare cancers (HGSRC). J Clin Med. 2021, 10:5978. 10.3390\/jcm10245978","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3171\/2023.5.FOCUS23168","article-title":"Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience","volume":"55","author":"Zamarud A","year":"2023","unstructured":"Zamarud A, Park DJ, Dadey DY, et al.. Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience. Neurosurg Focus. 2023, 55:E7. 10.3171\/2023.5.FOCUS23168","journal-title":"Neurosurg Focus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000675","article-title":"Outcomes and the role of primary histology following LINAC-based stereotactic radiation for sarcoma brain metastases","volume":"43","author":"Sim AJ","year":"2020","unstructured":"Sim AJ, Ahmed KA, Keller A, et al.. Outcomes and the role of primary histology following LINAC-based stereotactic radiation for sarcoma brain metastases. Am J Clin Oncol. 2020, 43:356-61. 10.1097\/COC.0000000000000675","journal-title":"Am J Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.02.007","article-title":"Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases","volume":"76","author":"Flannery T","year":"2010","unstructured":"Flannery T, Kano H, Niranjan A, et al.. Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases. Int J Radiat Oncol Biol Phys. 2010, 76:513-9. 10.1016\/j.ijrobp.2009.02.007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369318-stereotactic-radiotherapy-for-locally-recurrent-and-metastatic-soft-tissue-sarcoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:49:09Z","timestamp":1748346549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369318-stereotactic-radiotherapy-for-locally-recurrent-and-metastatic-soft-tissue-sarcoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.84886","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}